L-[1-13C] phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease**-Science-Chemical Encyclopedia-lookchem

L-[1-13C] phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease**
Add time:09/06/2019 Source:sciencedirect.com

BackgroundLiver disease is associated with impaired metabolism of these amino acids phenylalanine and tyrosine. Decreased metabolism of these amino acids leads to abnormal plasma elevations and impaired clearance rates. We have developed a noninvasive breath test that measures hepatic cytosolic enzyme activity.

We also recommend Trading Suppliers and Manufacturers of L-PHENYLALANINE (2-13C) (cas 136056-01-4). Pls Click Website Link as below: cas 136056-01-4 suppliers

Prev:The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C]tyrosine in the postabsorptive state
Next: Invited ReviewProperties of FDA-approved small molecule protein kinase inhibitors)

Encyclopedia